Capital Impact Advisors, LLC Bei Gene, Ltd. Transaction History

Capital Impact Advisors, LLC

  • $75.1 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$249.6 - $403.14 $3.14 Million - $5.06 Million
-12,561 Closed
0 $0
Q2 2021

Aug 17, 2021
BUY
$292.75 - $367.01 $2.08 Million - $2.61 Million
7,110 Added 130.43%
12,561 $4.31 Million
Q1 2021

May 18, 2021
BUY
$260.64 - $382.12 $1.42 Million - $2.08 Million
5,451 New
5,451 $1.9 Million

Others Institutions Holding BGNE

# of Institutions
216
Shares Held
45.1M
Call Options Held
76.5K
Put Options Held
72.3K
View Full List

About BeiGene, Ltd.

BGNE Quotes by TradingView
  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $15.2B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track Capital Impact Advisors, LLC Portfolio

Follow Capital Impact Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Impact Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email